Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_00410 |
| Species: | Homo sapiens |
| Position : | chr3:41177000-41179000 |
| Year: | 2021 |
| Title: | The osteoporosis risk variant rs9820407 at 3p221 acts as an allele-specific enhancer to regulate CTNNB1 expression by long-range chromatin loop formation |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| Disease Name: | -- |
| PMID: | 34461284 |
| MONDO: | |
| Tissue: | Embryonic Kidney |
| Tissue Ontology ID: | UBERON:0002113 |
| Cell Source: | HEK293 |
| CVCL ID: | CVCL_0063 |
| Cell Type: | embryonic kidney cell |
| Cell Ontology ID: | CL:0002139 |
| Experiment Type: | Enhancer activity assay, Chromatin interaction assay |
| High Throughput Method: | Hi-C, ChIP-seq |
| Low Throughput Method: | Luciferase Reporter Assay, RT-RT-qPCR |
| Target gene : | CTNNB1 |
| TF name : |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_00409 | chr3:41177000-41179000 | Bone | osteosarcoma cell | osteosarcoma |